Case Study

A Better Route For Commercial Manufacture: Improved Yields And Operability

Source: Asymchem

Early development routes are often unsuitable for large scale commercial manufacture. A new chemical process improved yields and operability.


A new process was needed for the commercial manufacturing of Ceralasertib, an experimental anti-cancer therapy with a challenging molecular structure comprised of a pyrimidine core decorated with a chiral morpholine, a cyclopropyl sulfoximine and an axaindote.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online